Literature DB >> 9124293

Linear dependence of muscle phosphocreatine kinetics on oxidative capacity.

A T Paganini1, J M Foley, R A Meyer.   

Abstract

The influence of muscle oxidative capacity on phosphocreatine (PCr) changes during and after stimulation was examined in the superficial (fast-twitch) section of rat gastrocnemius muscles. Muscle mitochondrial enzymes were increased in one group of rats by 8-10 wk of training on a running wheel (to a final regimen of 50 min/day at 38 m/min, 5 days/wk) and decreased in another group by chemical thyroidectomy [0.025% methimazole (MMI) in drinking water for 8 wk]. After these treatments, muscle citrate synthase activity was 179 and 29%, respectively, of that in corresponding control groups. Muscle PCr and pH were measured by 31P-nuclear magnetic resonance spectroscopy before, during, and after 8 min of isometric twitch stimulation at 0.33 Hz (MMI) or 0.75 Hz (trained) and 2 Hz. There was a significant linear correlation (r = 0.84, P < 0.01) between the rate constant for PCr recovery after submaximal stimulation (0.33 or 0.75 Hz) and citrate synthase activity. Within the control groups, there was a significant correlation (r = 0.72, P < 0.01) between the rate constant for PCr recovery and intracellular pH at the end of stimulation. The results are quantitatively consistent with linear/quasilinear models of respiratory control by the cytoplasmic free energy of ATP hydrolysis but not with respiratory control by cytoplasmic ADP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124293     DOI: 10.1152/ajpcell.1997.272.2.C501

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  70 in total

1.  Oxidative capacity and ageing in human muscle.

Authors:  K E Conley; S A Jubrias; P C Esselman
Journal:  J Physiol       Date:  2000-07-01       Impact factor: 5.182

2.  Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy.

Authors:  G J Kemp; M Roussel; D Bendahan; Y Le Fur; P J Cozzone
Journal:  J Physiol       Date:  2001-09-15       Impact factor: 5.182

3.  Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis.

Authors:  Jorge L Gamboa; Baback Roshanravan; Theodore Towse; Chad A Keller; Aaron M Falck; Chang Yu; Walter R Frontera; Nancy J Brown; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-26       Impact factor: 8.237

4.  Parameter estimation in modeling phosphocreatine recovery in human skeletal muscle.

Authors:  Laurent M Arsac; Eric Thiaudière; Philippe Diolez; Léo Gerville-Réache
Journal:  Eur J Appl Physiol       Date:  2003-11-19       Impact factor: 3.078

Review 5.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

6.  Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements.

Authors:  Ian R Lanza; Sumit Bhagra; K Sreekumaran Nair; John D Port
Journal:  J Magn Reson Imaging       Date:  2011-11       Impact factor: 4.813

Review 7.  In vivo MR investigation of skeletal muscle function in small animals.

Authors:  B Giannesini; P J Cozzone; D Bendahan
Journal:  MAGMA       Date:  2004-12-10       Impact factor: 2.310

8.  Determinants of repeated-sprint ability in females matched for single-sprint performance.

Authors:  David Bishop; Johann Edge
Journal:  Eur J Appl Physiol       Date:  2006-04-13       Impact factor: 3.078

Review 9.  Factors affecting the rate of phosphocreatine resynthesis following intense exercise.

Authors:  Shaun McMahon; David Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

10.  Acidosis inhibits oxidative phosphorylation in contracting human skeletal muscle in vivo.

Authors:  Sharon A Jubrias; Gregory J Crowther; Eric G Shankland; Rodney K Gronka; Kevin E Conley
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.